Calibrate and Found became two of the better-known direct-to-consumer medical weight-loss platforms in the US, both built around GLP-1 medication access paired with behavioral and nutritional support. This calibrate vs found comparison explains how the two platforms have positioned themselves, how their program structures, medication approaches, and costs have differed, and – importantly – how both have since changed. Read the status note below first: this is a fast-moving corner of digital health, and details here should be verified directly with each company before you rely on them. This article is general information, not medical advice, and Free Market Healthcare is not affiliated with, endorsed by, or sponsored by either company.
Current status – please verify. Both platforms have restructured since their peak direct-to-consumer era. Calibrate has shifted away from its original consumer 12-month program toward business, employer, and health-plan channels, and as of this update its consumer offering appears to be defunct or substantially reshaped. Found remains active but has reshaped its offering (for example, emphasizing lower-cost compounded and branded GLP-1 options and a Medicare-focused program). Because these companies change frequently, treat the comparisons below as historical/as-marketed context and confirm current availability, pricing, and terms on each company’s official site before making any decision.
Calibrate vs Found – how each was positioned
In their direct-to-consumer heyday, the two platforms had meaningfully different positioning. Calibrate was structured as a 12-month program built around intensive coaching, monthly clinician visits, and a curriculum aimed at durable behavior change. Found offered a more flexible, month-to-month subscription with a broader medication list and lighter, more app-based coaching. In short: Calibrate leaned toward structured, high-touch coaching alongside GLP-1 medication, while Found leaned toward flexibility and medication-formulary breadth. Both approaches have real merits, and both companies have since evolved. See our individual Calibrate review and Found review for platform-specific detail (also being kept current).
Cost and program structure (historical, as-marketed)
The figures below reflect how each platform marketed itself during its direct-to-consumer phase. They are provided for historical context only and should not be assumed to be current. A program fee is not insurance and generally does not include the medication, which is billed and priced separately.
Calibrate (as originally marketed):
- A structured 12-month “Total Care” program with a single up-front (or installment) program fee – historically reported in the range of roughly $1,600 for the year, though this changed over time
- Included a clinician evaluation, periodic clinician visits, regular coaching, an app-based curriculum, and biometric tracking
- Medication billed separately – insurance-covered or out-of-pocket, varying by drug
- A maintenance subscription after the initial year, and, at various points, a partial-refund “results guarantee” tied to engagement and weight-loss milestones
Found (as originally marketed):
- A flexible monthly subscription (historically in the low-hundreds-of-dollars-per-year range, with prepay discounts) rather than an up-front annual commitment
- Included a clinician evaluation, check-ins, asynchronous messaging with a prescriber, and app-based behavioral content
- Medication billed separately – ranging from inexpensive older generics to branded GLP-1s that can cost well over a thousand dollars a month without coverage
- More recently, Found has advertised lower-cost compounded and branded GLP-1 options and a Medicare-oriented program; confirm current specifics directly
Because both companies have repriced and repackaged their offerings, do not treat any dollar figure here as a quote. Check current pricing on each official site, and factor medication cost – which is usually the largest and most variable expense – separately from the program fee. For broader context on managing these costs, see our healthcare costs guide.
Coaching intensity – Calibrate’s traditional differentiator
Calibrate’s original model emphasized structured coaching: regularly scheduled sessions with a designated coach covering goal-setting, troubleshooting, and behavior change across the year, adding up to a substantial amount of one-on-one contact for engaged members. Found’s coaching was lighter by design – app-based behavioral content across nutrition, movement, sleep, and emotional health, with optional check-ins and higher-tier one-on-one coaching. For people who want and will use intensive coaching, the Calibrate-style model fit better; for self-directed people who did not want structured coaching, the lighter approach was a feature, not a weakness. Whether either company still offers coaching in this form should be confirmed directly.
Medication approach – Found’s traditional breadth
Calibrate’s formulary centered on FDA-approved GLP-1 weight-loss medications and was relatively narrow and GLP-1-focused. Found historically offered a broader toolkit that, alongside GLP-1 medications, could include older options used off-label for weight management in appropriate patients – for example metformin (often for insulin resistance), bupropion, naltrexone/bupropion combinations, or topiramate/phentermine combinations. Whether any specific drug is appropriate, and at what dose, is a clinical decision made by a licensed prescriber based on your health history – it is not something to select from an article.
This breadth mattered because not every patient is a GLP-1 candidate, not everyone can afford GLP-1s, and not everyone responds best to them. A wider formulary can fit a wider range of patient profiles. It also means the “right” platform depends heavily on your individual clinical situation.
A note on compounded GLP-1 medications
During the widespread GLP-1 shortages, some telehealth platforms offered compounded versions of semaglutide or tirzepatide at lower prices. As the FDA declared those shortages resolved, the legal basis for mass compounding narrowed and has been winding down, and this area remains contested and subject to enforcement and litigation. Compounded drugs are not FDA-approved products and can vary in quality and safety. If any platform offers a compounded GLP-1, treat it with caution: confirm that the pharmacy is legitimate and appropriately licensed, understand that availability may change, and discuss the risks and legality with a licensed clinician before starting. Never buy prescription weight-loss medication from a source that does not require a prescription and clinical evaluation.
Clinical assessment and outcomes
Found historically marketed a fairly detailed intake covering metabolic markers, prior weight-loss attempts, and contraindications, used to inform medication selection across its broader formulary. Calibrate marketed structured outcome data and, at times, a results guarantee, with published average weight-loss figures for program completers. Outcome claims from any commercial program should be read cautiously – they often reflect completers rather than everyone who enrolls, and individual results vary. Sustainable results depend on many factors beyond the platform, including the medication, adherence, and personal circumstances.
Insurance, and what a subscription does and does not cover
A key point that applies to both: the program subscription is not health insurance. Historically, neither platform billed insurance for the program fee – that was out-of-pocket – while both coordinated medication prescriptions with pharmacies where a patient’s insurance could apply to the drug. So two separate cost questions matter: (1) the program/service fee, and (2) whether and how your insurance covers the prescribed medication. GLP-1 coverage for weight management varies enormously by plan and changes frequently, so verify your specific benefits directly with your insurer.
How both compared to Hims, Ro, and Noom Med
Compared with Hims and Ro weight-loss programs, both Calibrate and Found historically offered more structured support – Hims and Ro leaned toward streamlined medication access with lighter coaching. Compared with Noom Med, both leaned on clinical infrastructure while Noom leaned on its behavioral curriculum. These competitors have also changed their offerings over time, so treat any comparison as a snapshot and verify current details. See our Found vs Noom comparison for a related breakdown.
Which model fits which patient (in general terms)
A Calibrate-style program historically suited people who wanted structured, higher-touch coaching, were comfortable with a longer commitment, and were strong GLP-1 candidates. A Found-style program historically suited people who wanted flexibility, potentially broader (including non-GLP-1) medication options, and lighter coaching with a detailed clinical assessment. But because both have restructured, the more important step today is to confirm what each actually offers now, and to have a licensed clinician determine what is appropriate for you.
Frequently Asked Questions
Are Calibrate and Found still operating the same way?
No. Both have changed. Calibrate has moved away from its original consumer 12-month model toward business/employer and health-plan channels, and its consumer offering appears defunct or reshaped as of this update. Found remains active but has reshaped its offering. Confirm the current status of each on its official site before relying on any detail here.
Which was cheaper, Calibrate or Found?
Historically, Found’s flexible monthly model could total a similar amount over a year to Calibrate’s up-front annual fee, and Found’s broader (including non-GLP-1) options could reduce total cost for people who did not need GLP-1s. But medication cost – usually the biggest and most variable expense – is separate from the program fee. Verify current pricing directly.
Does either program take insurance?
Historically, neither billed insurance for the program fee itself; both coordinated medication prescriptions where a patient’s insurance could apply to the drug. A subscription is not insurance. Check your own plan’s coverage for any prescribed medication.
Which prescribes Wegovy, Zepbound, or other GLP-1s?
Both historically prescribed FDA-approved GLP-1 weight-loss medications when clinically appropriate, and Found also prescribed a broader range of options. Whether a specific medication is right for you – and at what dose – is a clinical decision for a licensed prescriber, not something to choose from an article.
Is it safe to use compounded GLP-1 medication from a telehealth platform?
Compounded drugs are not FDA-approved products, availability has been winding down as shortages resolved, and the area is legally contested. If considering one, verify the pharmacy is legitimate and licensed, discuss risks with a licensed clinician, and never use a source that skips a real prescription and evaluation.
The bottom line on Calibrate vs Found
Calibrate and Found were built on genuinely different philosophies – Calibrate around structured, intensive coaching within a defined program, and Found around flexibility, broader medication options, and lighter coaching. Both have since restructured, so the most useful thing you can do is verify what each currently offers, confirm your own insurance coverage for any medication, and let a licensed clinician decide what treatment is appropriate for you. Whatever platform you consider, remember that GLP-1 and other weight-loss medications are prescription-only and prescriber-directed, a subscription is not insurance, and no article can substitute for individualized medical advice.
Medical and accuracy disclaimer: This article is for general informational purposes only and is not medical, financial, or purchasing advice. Free Market Healthcare is not affiliated with, endorsed by, or sponsored by Calibrate or Found. Both companies have restructured, and program details, pricing, and availability change frequently and could not be fully independently confirmed here – verify everything directly with each company. GLP-1 and other weight-loss medications are prescription-only; dosing and suitability are clinical decisions for a licensed prescriber. Compounded medications are not FDA-approved and are legally contested. Confirm insurance coverage with your own plan.
Sources
- U.S. Food and Drug Administration (FDA) – GLP-1 medications, compounding rules, and drug-shortage status updates (fda.gov)
- Calibrate (calibrate.com) and Found (joinfound.com) – public/marketing materials; current status not independently confirmed and subject to change
- Free Market Healthcare project history – notes on Calibrate’s and Found’s restructuring (internal, for context; verify against primary sources)